Back to top
more

Amgen (AMGN)

(Delayed Data from NSDQ)

$270.32 USD

270.32
2,322,805

+8.09 (3.09%)

Updated Jan 13, 2025 03:57 PM ET

After-Market: $270.13 -0.19 (-0.07%) 4:26 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.35%
2Buy18.11%
3Hold9.74%
4Sell5.34%
5Strong Sell2.80%
S&P50011.41%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 250)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Balance Sheet

Research for AMGN

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Amgen Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Assets          
Cash & Equivalents -99,999 10,944 9,305 8,037 10,647
Receivables NA 7,268 5,563 4,895 4,525
Notes Receivable NA 0 0 0 0
Inventories NA 9,518 4,930 4,086 3,893
Other Current Assets NA 2,602 2,388 2,367 2,079
Total Current Assets NA 30,332 22,186 19,385 21,144
Net Property & Equipment NA 5,941 5,427 5,184 4,889
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 51,270 31,609 30,072 31,276
Deposits & Other Assets NA 9,611 5,899 6,524 5,639
Total Assets NA 97,154 65,121 61,165 62,948
Liabilities & Shareholders Equity 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Notes Payable NA 0 0 0 0
Accounts Payable NA 1,590 1,572 1,366 1,421
Current Portion Long-Term Debt NA 1,443 1,591 87 91
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 15,359 12,524 10,731 10,141
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 18,392 15,687 12,184 11,653
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 2,354 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 63,170 37,354 33,222 32,895
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 7,006 8,419 9,059 8,991
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 90,922 61,460 54,465 53,539
Shareholders Equity 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 33,070 32,514 32,096 31,802
Capital Surplus NA 0 0 0 0
Retained Earnings NA -26,549 -28,622 -24,600 -21,408
Other Equity NA -289 -231 -796 -985
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 6,232 3,661 6,700 9,409
Total Liabilities & Shareholder's Equity NA 97,154 65,121 61,165 62,948
Total Common Equity 0 6,232 3,661 6,700 9,409
Shares Outstanding 537.50 535.10 533.50 558.30 582.10
Book Value Per Share 0.00 11.65 6.86 12.00 16.16

Fiscal Year End for Amgen Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023
Assets          
Cash & Equivalents -99,999 9,011 9,301 9,708 10,944
Receivables NA 7,317 6,934 6,776 7,268
Notes Receivable NA 0 0 0 0
Inventories NA 7,362 7,995 8,724 9,518
Other Current Assets NA 3,076 2,976 2,821 2,602
Total Current Assets NA 26,766 27,206 28,029 30,332
Net Property & Equipment NA 6,156 6,097 6,002 5,941
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 47,578 48,788 49,942 51,270
Deposits & Other Assets NA 10,383 8,816 9,007 9,611
Total Assets NA 90,883 90,907 92,980 97,154
Liabilities & Shareholders Equity 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 2,147 2,267 1,628 1,590
Current Portion Long-Term Debt NA 3,544 5,528 3,959 1,443
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 14,621 13,722 14,127 15,359
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 20,312 21,517 19,714 18,392
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 1,711 1,780 1,862 2,354
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 56,854 57,117 60,061 63,170
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 4,568 6,321 7,006
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 83,356 84,982 87,958 90,922
Shareholders Equity 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 33,393 33,204 33,082 33,070
Capital Surplus NA 0 0 0 0
Retained Earnings NA -25,530 -27,124 -27,870 -26,549
Other Equity NA -336 -155 -190 -289
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 7,527 5,925 5,022 6,232
Total Liabilities & Shareholder's Equity NA 90,883 90,907 92,980 97,154
Total Common Equity 0 7,527 5,925 5,022 6,232
Shares Outstanding 537.50 537.50 536.40 536.40 535.10
Book Value Per Share 0.00 14.00 11.05 9.36 11.65